| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Parvalbumin alpha;PVALB; |
| Cellular Localization | |
| Clonality | |
| Concentration | |
| Form | Liquid |
| Gene ID | |
| Host | |
| Immunogen | A synthesized peptide derived from human GABA A Receptor beta 2 |
| Isotype | |
| Molecular Weight | |
| Product Type | |
| Reactivity | |
| Reconstitution | |
| Storage | |
| Target | |
| UniProt # |
Overview
This product is an anti-GABRB2 antibody for target detection and characterization. Key identifiers include host species: Rabbit; Monoclonal; clone 18G45; isotype IgG; reactivity: Human,Mouse,Rat. Reported application contexts include WB (as provided in the source record). Boster Bio Anti-GABA A Receptor beta 2 Rabbit Monoclonal Antibody catalog # M04049. Tested in WB application. This antibody reacts with Human, Mouse, Rat.
Key elements and design rationale
- Target: GABRB2 (Parvalbumin alpha).
- Antibody format: Monoclonal; clone 18G45; isotype IgG.
- Host: Rabbit.
- Species reactivity: Human,Mouse,Rat (confirm in your model system with appropriate controls).
This description is intended to help interpret the antibody design and the biological context of the target using the fields provided in the catalog record, alongside general experimental considerations.
Biological background
GABRB2 (protein: T-cell surface glycoprotein CD3 zeta chain) is a commonly studied target in molecular and cellular biology. Functional context (as provided): In muscle, parvalbumin is thought to be involved in relaxation after contraction. It binds two calcium ions. Reported cellular localization context: Mitochondrion outer membrane ; Single-pass membrane protein . Tissue expression notes (as provided): Mainly expressed in endothelial cells lining lymphatic vessels. .
Research relevance and current trends
- Research context keywords from the source record include: Calcium Binding Proteins,Calcium Signaling,Neuroscience,Neurotransmission.
- Current studies often focus on connecting target abundance/localization to pathway perturbations across models, tissues, and cell states.
- Quantitative and multiplexed assays (e.g., imaging + immunoblot panels) are commonly used to compare phenotypes across conditions and time-courses.
Common research applications
- Western blotting (WB): assess relative target abundance across samples, treatments, or time-points.
Workflow ideas (metafield): Validate GABRB2 antibody specificity using KO/KD control samples (WB/IF/IHC as appropriate), Detect GABRB2 expression by Western blot in cell or tissue lysates, Compare relative GABRB2 levels across experimental conditions (dose/time-course) using antibody-based readouts
Notes for experimental interpretation
- Consider isoforms and post-translational modifications (PTMs) that may shift apparent molecular weight or epitope accessibility.
- Apparent molecular weight may vary by sample type and processing (observed MW: 37 kDa; calculated MW: 12059 MW).
- Control concepts: include appropriate negative controls (e.g., isotype, KO/KD samples) and orthogonal validation when feasible.
Additional product details (from the source record)
- Molecular weight (observed): 37 kDa
- Cellular localization (provided): Mitochondrion outer membrane ; Single-pass membrane protein .
- Tissue details (provided): Mainly expressed in endothelial cells lining lymphatic vessels. .
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
